These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding. Walter A, Rudler M, Olivas P, Moga L, Trépo E, Robic MA, Ollivier-Hourmand I, Baiges A, Sutter O, Bouzbib C, Peron JM, Le Pennec V, Ganne-Carrié N, Garcia-Pagán JC, Mallet M, Larrue H, Dao T, Thabut D, Hernández-Gea V, Nault JC, Bureau C, Allaire M, Salvage TIPS Group. Hepatology; 2021 Oct; 74(4):2085-2101. PubMed ID: 34018627 [Abstract] [Full Text] [Related]
12. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis. Heinzow HS, Lenz P, Köhler M, Reinecke F, Ullerich H, Domschke W, Domagk D, Meister T. World J Gastroenterol; 2012 Oct 07; 18(37):5211-8. PubMed ID: 23066315 [Abstract] [Full Text] [Related]
13. Right atrial pressure may impact early survival of patients undergoing transjugular intrahepatic portosystemic shunt creation. Parvinian A, Bui JT, Knuttinen MG, Minocha J, Gaba RC. Ann Hepatol; 2014 Oct 07; 13(4):411-9. PubMed ID: 24927612 [Abstract] [Full Text] [Related]
14. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures. Lee BT, Yang AH, Urban S, Kim KY, Ter-Oganesyan R, Yuan L, Han HH, Khemichian S, Kahn JA, Kim B. Eur J Gastroenterol Hepatol; 2021 Apr 01; 33(4):541-546. PubMed ID: 32398491 [Abstract] [Full Text] [Related]